| Previous 10 |
Ad
MURA News and Press Mural Oncology plc From 11/20/24
News | Mural Oncology plc (NASDAQ:MURA)
-
Nemvaleukin was generally well tolerated in ARTISTRY-1, a completed phase 1/2 clinical trial, with durable responses observed in both monotherapy and combination therapy across a range of heavily pretreated advanced solid tumors, including in platinum-resistant ovarian cancer (PROC), which does n...
-
2024-11-13 11:09:32 ET More on Mural Oncology plc Historical earnings data for Mural Oncology plc Financial information for Mural Oncology plc Read the full article on Seeking Alpha For further details see: Mural Oncology plc GAAP EPS of -$1.87 beats by $...
-
Company remains on track in late-stage, potentially registrational trials of nemvaleukin alfa, with data readouts expected in late Q1/early Q2 2025 for platinum-resistant ovarian cancer and Q2 2025 for mucosal melanoma Candidate nominations for IL-18 and IL-12 programs expected in Q4 2024...
-
WALTHAM, Mass. and DUBLIN, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to address areas of unmet need for patients with a variety of cancers, today announ...
-
Less frequent IV dosing with nemvaleukin in patients with select advanced solid tumors, including ovarian cancer and mucosal melanoma, showed tumor site-specific pharmacodynamic activity and immune activation Preclinical data demonstrated durable immune responses and tumor growth inhibiti...
Stock Information
Get MURA Alerts
News, Short Squeeze, Breakout and More Instantly...
Mural Oncology plc Company Name:
MURA Stock Symbol:
NASDAQ Market:
0.0% G/L:
$2.53 Last:
121,654 Volume:
$2.56 Open:
$2.53 Close:
Ad
-
urban-gro Inc. (UGRO) is expected to report for quarter end 2025-03-31 Karman Holdings Inc. (KRMN) is expected to report $0.02 for Q1 2025 PyroGenesis Inc Com (PYRGF) is expected to report for quarter end 2025-03-31 GeoVax Labs Inc. (GOVX) is expected to report $-0.59 for Q1 2025 ...
-
2025-05-12 18:48:12 ET Mural Oncology plc (MURA) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 3.91%. The average open to low on the day of earnings was -2.76%. The average open to clo...
-
2025-05-12 18:43:11 ET Mural Oncology plc (MURA) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in MURA stock price following earnings has averaged ±1.58% , with a median of 1.08%. T...